SCHEMBL4804428

SCHEMBL4804428

NS(=O)(=O)c1ccon1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trimethylammonium SCHEMBL27754830 0.92 CA2 (0.36)
Naphthalene SCHEMBL7850037 0.90 LMNA (0.41)
Biphenyl SCHEMBL5706278 0.88 CA2 (0.47)
SCHEMBL329815 0.78
SCHEMBL1259248 0.76
SCHEMBL29207412 0.74 TSHR (0.31)
SCHEMBL3177230 0.71 ALDH1A1 (0.35)
SCHEMBL11004258 0.70 MEN1 (0.35)
SCHEMBL6403890 0.70 HTR6 (0.50)
Acetic Acid SCHEMBL28527454 0.69 RAB9A (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120157627-A Isoxazole sulfonamide derivative compound and preparation method and application thereof 东北农业大学 2025-06-17 CN claimed
CN-113651766-B Isoxazole sulfonamide compound with BRD4 inhibitory activity, and preparation method and application thereof 泰州职业技术学院 2023-08-18 CN claimed
CN-113651766-A Isoxazole sulfonamide compound with BRD4 inhibitory activity and preparation method and application thereof 泰州职业技术学院 2021-11-16 CN claimed
EP-3600296-A1 NOVEL COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING INSULIN RESISTANCE Université Paris Diderot (FR) 2020-02-05 EP claimed
EP-0699191-A1 SULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN TEXAS BIOTECHNOLOGY CORPORATION (US) 1996-03-06 EP claimed
WO-1994027979-A1 SULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN IMMUNOPHARMACEUTICS, INC. (US) 1994-12-08 WO claimed
CN-120157627-A Isoxazole sulfonamide derivative compound and preparation method and application thereof 东北农业大学 2025-06-17 CN disclosed
CN-120157627-A Isoxazole sulfonamide derivative compound and preparation method and application thereof 东北农业大学 2025-06-17 CN disclosed
CN-120157627-A Isoxazole sulfonamide derivative compound and preparation method and application thereof 东北农业大学 2025-06-17 CN disclosed
EP-4558497-A1 NOVEL ISOTHIAZOL-3-YL AND ISOXAZOL-3-YL SULFONAMIDE COMPOUNDS F. Hoffmann-La Roche AG (CH) 2025-05-28 EP disclosed
CN-113227131-B Modified antibody Fc and methods of use thereof 豪夫迈·罗氏有限公司 2025-03-04 CN disclosed
WO-2024017855-A1 NOVEL ISOTHIAZOL-3-YL AND ISOXAZOL-3-YL SULFONAMIDE COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2024-01-25 WO disclosed
WO-2024017855-A1 NOVEL ISOTHIAZOL-3-YL AND ISOXAZOL-3-YL SULFONAMIDE COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2024-01-25 WO disclosed
WO-1997038986-A1 SUBSTITUTED BENZENESULFONAMIDE DERIVATIVES AS PRODRUGS OF COX-2 INHIBITORS G.D. SEARLE & CO. (US) 1997-10-23 WO disclosed
CN-1143639-A Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1997-02-26 CN disclosed
US-5571821-A CARDIOVASCULAR DISORDERS TO MODULATE ENDOTHELIN, HYPOTENSIVE AGENTS AND VASOCONSTRICTION TEXAS BIOTECHNOLOGY CORPORATION (US) 1996-11-05 US disclosed
EP-0702012-A1 Substituted isoxazole sulfonamides and their use as endothelin antagonists BRISTOL-MYERS SQUIBB COMPANY (US) 1996-03-20 EP disclosed
EP-0699191-A1 SULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN TEXAS BIOTECHNOLOGY CORPORATION (US) 1996-03-06 EP disclosed
WO-1994027979-A1 SULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN IMMUNOPHARMACEUTICS, INC. (US) 1994-12-08 WO disclosed
EP-0234352-B1 SULFONAMIDE COMPOUNDS AND SALTS THEREOF, HERBICIDAL COMPOSITIONS CONTAINING THEM, AND PROCESS FOR PRODUCING THEM ISHIHARA SANGYO KAISHA, LTD. (JP) 1992-04-29 EP disclosed